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Abstract 
We examined the effects of physical activity and the apolipoprotein E e4 allele 
(APOEe4) on age-related cognitive decline amongst a sample of cognitively normal 
middle-aged and older adults. Forty-seven participants (76.6% female; 23.4% male) 
aged 50-71 at baseline (M = 60.0, SD = 5.8) wore an accelerometer to record total 
weekly level of physical activity. Participants also underwent APOE genotyping and 
annual cognitive tests assessing long-term memory and learning, working memory, 
and executive functioning through the Tasmanian Healthy Brain Project. We 
conducted a series of three-way mixed analyses of variance to test for interaction 
effects between physical activity status (active; inactive), APOEe4 status (carrier; 
non-carrier), and assessment phase (1; 2; 3; 4) on performance on each of the 
cognitive tests. For all cognitive tests, there were no consistent effects of physical 
activity, no consistent effects of APOEe4, and no significant interaction effects 
between physical activity, APOEe4, and phase of assessment. Findings suggest that 
physical activity, APOEe4, or combinations of the two do not influence non-
pathological age-related cognitive decline. Future research would benefit from 
examining the possibility that APOEe4 may be detrimental to cognitive decline for 
individuals that carry two copies of the allele, and from examining whether lifetime 
levels of physical activity or specific types of physical activity influence age-related 
cognitive decline.  
Keywords: ageing, long-term memory, working memory, executive functioning, 
gene-environment interaction 
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Introduction 
 Growing old is associated with a gradual decline in cognitive function 
(Salthouse, 2009). This cognitive decline is typically characterised by subtle 
decreases in memory performance, speed of processing, and executive functioning 
and does not significantly impair daily functioning (Park et al., 2002; Park & Reuter-
Lorenz, 2009). Although cognitive decline is a normal consequence of ageing, it can 
nonetheless be distressing for individuals and their families to experience. Normal 
age-related cognitive decline begins prior to the age of 60 years (Salthouse, 2009). 
As life expectancy is increasing and the worldwide population is ageing (World 
Health Organization, 2015), it is expected that the number of individuals 
experiencing age-related cognitive decline at any one time will increase over future 
years. 
 While most people experience cognitive decline as they age, some individuals 
decline at a faster rate than others. A pronounced rate of cognitive deterioration can 
be indicative of dementia, such as Alzheimer's disease, and is not part of the normal 
ageing process (McKhann et al., 2011). Past research into later-life cognition has 
largely focused on the effectiveness of treatment interventions in alleviating the 
pathogenic processes that are present in clinical and pre-clinical stages of 
Alzheimer's disease. However, these interventions have been largely unsuccessful 
(Brini et al., 2017). It is possible that this is because the interventions are 
administered during the symptomatic stages of Alzheimer's disease, at which point 
irreversible neural damage has already taken place (Sperling, Jack, & Aisen, 2011). 
Identifying factors that may influence the rate of age-related cognitive decline, prior 
to clinically significant cognitive impairment, may be more effective at reducing the 
burden of dementia and Alzheimer's disease. Additionally, it may be possible to 
identify preventative interventions which could benefit older adults who wish to 
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delay or slow normal age-related cognitive decline, not only those at increased risk 
of dementia. 
 Two factors that may influence the rate of age-related cognitive decline are 
physical activity and the epsilon 4 (e4) allele of the apolipoprotein E gene (APOE). 
Physical activity refers to "any bodily movement produced by skeletal muscles that 
results in energy expenditure" (Caspersen, Powell, & Christenson, 1985, p. 126), and 
has been recognised as a modifiable behaviour that mitigates age-related cognitive 
decline (Sofi et al., 2010). In contrast, the e4 allele of the APOE gene has been 
associated with an increased rate of cognitive decline in normal ageing (Small, 
Rosnick, Fratiglioni, & Bäckman, 2004). While an individual cannot change their 
genetic status, it is possible that physical activity may interact with the influence of 
APOEe4 on age-related cognitive decline. An understanding of whether physical 
activity interacts with APOEe4 could help to develop potential interventions to delay 
or slow age-related cognitive decline. 
Physical Activity and Cognitive Decline 
 Physical activity is known to improve and maintain neurocognitive health 
(Stillman, Cohen, Lehman, & Erickson, 2016). Prospective cohort studies have 
shown that cognitively normal older adults who engage in regular physical activity 
experience less decline in the cognitive domains of executive functioning and 
processing speed, as well as general cognitive performance (Best et al., 2017; 
Frederiksen et al., 2015; Sofi et al., 2010). Additionally, those who are physically 
active are less likely to be cognitively impaired or be diagnosed with Alzheimer's 
disease, compared to those who are inactive (Barnes et al., 2008; Buchman et al., 
2012; Wang et al., 2013). The protective effects of physical activity on cognitive 
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decline seem to be greatest at high levels of physical activity, but are also significant 
at low and moderate levels (Sofi et al., 2010).  
 Several possible mechanisms for the protective effect of physical activity on 
cognitive function have been suggested. Firstly, physical activity increases blood 
levels of brain-derived neurotrophic factor, insulin-like growth factor-1, and vascular 
endothelial-derived growth factor. In turn, combinations of these growth factors 
regulate neuroplasticity, neurogenesis and cerebrovascular perfusion, all of which are 
imperative to cognitive function (Cotman, Berchtold, & Christie, 2007; Stillman et 
al., 2016). Furthermore, physical activity is known to reduce peripheral risk factors 
for cognitive decline, including systemic inflammation, hypertension, 
hyperglycaemia, and dyslipidaemia (Cotman et al., 2007; Stillman et al., 2016). 
Finally, physical activity is also thought to indirectly benefit cognition through its 
beneficial influence on stress, mood, and sleep (Cotman et al., 2007; Sofi et al., 
2010; Stillman et al., 2016). 
The APOE Gene and Cognitive Decline 
 Past research suggests that physical activity is beneficial in mitigating age-
related cognitive decline. However, even when accounting for level of physical 
activity, inter-individual differences remain. It is possible that genetic factors account 
for some of these inter-individual differences. One genetic factor that influences 
cognitive decline is the APOE gene (Small et al., 2004).  
 The APOE gene synthesises apolipoprotein E (ApoE), which is a plasma 
protein (Small et al., 2004). The main functions of ApoE include lipid transport, 
cholesterol metabolism, and processes involved in neuronal repair (Liu, Kanekiyo, 
Xu, & Bu, 2013; Phillips, 2014; Small et al., 2004). There are three main allelic 
variations of the APOE gene, e2, e3, and e4, and each allele provides the genetic 
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information for a different isoform of ApoE (Phillips, 2014). Individuals inherit one 
allele from each parent, allowing for six possible genotypes, e2/e2; e2/e3; e2/e4; 
e3/e3; e3/e4; e4/e4 (Small et al., 2004). The e3 allele is the most common allele 
amongst the worldwide population with a frequency of 72%, followed by e4 (17%) 
and e2 (11%; Zannis, Kardassis, & Zannis, 1993). 
 The e4 allele of the APOE gene is recognised as a risk factor for pathological 
cognitive decline, with it known as the primary genetic risk factor for Alzheimer's 
disease (Harold et al., 2009; Lindsay et al., 2002). Individuals who carry one copy of 
APOEe4 are at a 3-4 times increased risk of Alzheimer's disease, while individuals 
who carry two copies of the e4 allele are at a 10-12 times increased risk of 
Alzheimer's disease, compared to those who do not carry APOEe4 (Farrer et al., 
1997). Additionally, amongst individuals with a diagnosis of Alzheimer's disease, 
APOEe4 carriers typically show an earlier onset (Corder et al., 1993; Farrer et al., 
1997), and a faster rate of cognitive decline (Martins, Oulhaj, de Jager, & Williams, 
2005), compared to non-carriers. 
 Moreover, research suggests that the presence of APOEe4 has a detrimental 
effect on cognitive decline in normal ageing (Small et al., 2004; Wisdom, Callahan, 
& Hawkins, 2011). Those who carry APOEe4 are more likely to experience 
multiple-domain decline, despite retaining a normal clinical status, than those who do 
not carry APOEe4 (Caselli et al., 2007). Healthy APOEe4 carriers typically show an 
increased rate of age-related decline across several domains of cognition, including 
verbal memory, episodic memory and executive function, as well as global cognitive 
functioning (Caselli et al., 2004; Caselli et al., 2007; Small et al., 2004). The 
increased rate of memory decline for APOEe4 carriers becomes apparent prior to the 
age of 60 years (Caselli et al., 2009). Taken together, these findings suggest that 
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APOEe4 has a detrimental influence on normal age-related cognitive decline. 
However this finding is not consistent, with some studies showing no independent 
effect of the e4 allele on cognition amongst healthy older adults (Foster et al., 2013; 
Ward et al., 2014; Quintas et al., 2014). 
 Several possible mechanisms for the potentially detrimental influence of 
APOEe4 on cognitive decline have been suggested. Firstly, cognitively normal 
individuals who carry APOEe4 show reduced cerebrospinal fluid amyloid beta 42 
and increased cortical binding potential for Pittsburgh Compound-B, which together 
reflect increased cerebral amyloid beta deposition (Morris et al., 2010; Wirth, 
Villeneuve, La Joie, Marks, & Jagust, 2014). This amyloid beta deposition is thought 
to contribute to cognitive decline (Jack et al., 2010). Additionally, cognitively normal 
APOEe4 carriers show reduced rates of cerebral glucose metabolism (Reiman et al., 
2004; Reiman et al., 2005; Small et al., 2000) and reduced grey matter volume and 
cortical thickness (Burggren et al., 2008; Fennema-Notestine et al., 2011), each of 
which are associated with cognitive decline. 
The Interaction Between Physical Activity and APOEe4 
 Physical activity and APOEe4 have each been shown to influence age-related 
cognitive decline, however the interaction between these factors is unclear. In terms 
of overall cognitive functioning, a study by Obisesan, Umar, Paluvi, and Gillum 
(2012) found that being physically active, relative to being sedentary, was associated 
with better cognitive performance amongst healthy adults aged 60-69 years, but only 
for non-APOEe4 carriers. There was no association between physical activity and 
cognitive function amongst APOEe4 carriers. Relatedly, Podewils et al. (2005) found 
an inverse relationship between physical activity level and dementia risk amongst 
men and women aged 65 years and older, but this relationship was absent in APOEe4 
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carriers. Similarly, two studies conducted by Tolppanen et al. (2015) and Kulmala et 
al. (2014) found that higher levels of physical activity during midlife were associated 
with a lower risk of dementia diagnosis in later life, and this benefit was more 
pronounced amongst non-APOEe4 carriers, compared to APOEe4 carriers.  
 These findings suggest that the beneficial effects of physical activity are not 
strong enough to overcome the potentially detrimental influence of APOEe4 on 
cognition. However, all of these studies used the Mini-Mental State Examination 
(MMSE) to measure cognitive decline. The MMSE is a brief questionnaire that 
assesses global cognitive functioning and is not sensitive to performance differences 
between specific domains of cognition (Magni, Binetti, Bianchetti, Rozzini, & 
Trabucchi, 1996). However, some cognitive domains appear to be influenced more 
by physical activity and APOEe4 than others. Specifically, physical activity appears 
to have the greatest influence on executive function and processing speed in the 
absence of APOE grouping (Netz, Dwolatzky, Zinker, Argov, & Agmon, 2011; 
Wilbur et al., 2012), while APOEe4 appears to have a greater influence on executive 
function and episodic memory compared to other cognitive domains (Small et al., 
2004). Thus, it is possible that studies examining the effects of physical activity and 
APOEe4 on domain-specific cognitive decline have a different pattern of results. 
 Indeed, a prospective cohort study of cognitively normal adults aged 45 years 
and older conducted by Pizzie et al. (2014) found that higher baseline physical 
activity was associated with small improvements in executive functioning and 
working memory performance over the subsequent four years, but only amongst 
APOEe4 carriers. There was no association between physical activity and decline 
trajectories of cognitive performance for non-APOEe4 carriers. Similar findings 
were reported by Thibeau, McFall, Camicioli, and Dixon (2017) who found that 
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lower physical activity levels were significantly associated with poorer baseline 
executive functioning and a more rapid decline in executive functioning amongst 
middle aged and older adults, but only for APOEe4 carriers. Finally, Etnier et al. 
(2007) found that greater levels of aerobic fitness were associated with better short-
term, long-term, and working memory performance amongst middle aged and older 
women, but this association was only significant for those who carried two copies of 
APOEe4. 
 This pattern of results has also been found in some studies assessing global 
cognitive functioning. For example, Woodward et al. (2012) found that physical 
activity reduced the risk of cognitive decline amongst healthy older adults, but only 
for APOEe4 carriers. Furthermore, Niti, Yap, Kua, Tan, and Ng (2008) found that 
higher levels of physical activity were associated with lower odds of cognitive 
decline amongst healthy adults aged 55 years and older, and that this association was 
stronger for APOEe4 carriers, compared to non-APOEe4 carriers. Similarly, Schuit, 
Feskens, Launer, and Kromhout (2001) found that elderly men who engage in more 
than one hour of physical activity per day had lower odds of cognitive decline than 
those who engage in less than one hour of activity. Again, this difference was greater 
for APOEe4 carriers, compared to non-APOEe4 carriers. Finally, greater levels of 
physical activity have been associated with reduced odds of dementia and 
Alzheimer's disease, and these associations are more evident amongst APOEe4 
carriers, compared to non-APOEe4 carriers (Luck et al., 2014; Kivipelto et al., 2008; 
Rovio et al., 2005; Tan et al., 2017; Yang et al., 2015).  
The Scaffolding Theory of Ageing and Cognition  
 These findings suggest that physical activity is protective of later-life 
cognition, and the benefits are particularly pronounced for individuals who carry the 
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e4 allele of the APOE gene. One explanation of these findings is the Scaffolding 
Theory of Ageing and Cognition. This theory suggests that compensatory brain 
processes take place in order to maintain normal cognitive function in later life, 
despite the accumulation of ageing-related brain changes (Park & Reuter-Lorenz, 
2009). These compensatory processes, often broadly referred to as neural 
scaffolding, may involve the engagement of increased neural circuitry and greater 
activation or recruitment of brain regions (Reuter-Lorenz & Park, 2014).  
 In accordance with this theory, research has found that cognitively healthy 
individuals who carry the APOEe4 allele typically exhibit increased task-related 
activity in multiple brain areas compared to their non-APOEe4 carrier counterparts 
(Bookheimer et al., 2000; Rao et al., 2015; Smith et al., 2011). Presumably, this 
increased brain activity occurs to compensate for the potentially detrimental 
influence that APOEe4 may have on cognitive decline (Rao et al., 2015). In addition, 
the current model of the Scaffolding Theory of Ageing and Cognition posits that 
lifestyle factors such as physical activity enhance neural scaffolding (Reuter-Lorenz 
& Park, 2014). Thus, physical activity may help to maintain cognitive function by 
enhancing neural scaffolding, which may be especially important for APOEe4 
carriers who may need to engage greater neural scaffolding in order to overcome the 
detrimental influence of APOEe4 on cognitive decline.  
Present Research 
 Although some studies suggest that the benefits of physical activity to 
cognitive decline may be particularly pronounced for APOEe4 carriers, there is no 
clear consensus. This may be because different studies have assessed different 
cognitive domains, and many studies have examined only global cognitive 
functioning. Some cognitive domains appear to be more amenable to the influence of 
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physical activity and APOEe4 than others. This disparity across different cognitive 
domains may explain why the interaction between physical activity and APOEe4 has 
been inconsistent across different studies. In the present study, we aim to overcome 
this limitation by including several validated cognitive measures to assess a range of 
cognitive domains. 
 Additionally, past research has relied predominantly on participants' self-
reports as an indication of physical activity levels. Self-report is susceptible to recall 
bias and response bias, and accurate reporting may be especially challenging 
amongst older cohorts (Buchman et al., 2012; Prince et al., 2008). Self-reported 
levels of physical activity are typically higher than objectively measured levels of 
physical activity (Prince et al., 2008). Additionally, most self-report physical activity 
questionnaires do not measure non-exercise levels of physical activity, which may be 
an important contributor to the overall health benefits that amass from physical 
activity (Levine, 2007; Matthews et al., 2007). Therefore, studies relying on self-
report as a measure of physical activity may not accurately capture the true effect of 
physical activity on cognitive decline.  
 One study by Buchman et al. (2012) used accelerometers, small devices worn 
on the body that record movement, to objectively record older adults' levels of 
physical activity. As predicted, they found that total daily physical activity was 
inversely associated with rate of cognitive decline, but they did not examine the 
interaction between physical activity and APOEe4. In the present study, we aim to 
overcome the limitations associated with self-report measures by using 
accelerometers to measure total weekly physical activity. Accelerometers are an ideal 
tool because they can be used to measure physical activity in free-living conditions, 
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meaning that measurements have high levels of external validity (Aadland & 
Ylvisåker, 2015), and because they capture total daily levels of physical activity.  
 The present study was designed to examine the influence of physical activity 
and APOEe4 on age-related cognitive decline amongst cognitively normal middle 
aged and older adults. To our knowledge, this is the first study of its kind to employ 
the use of accelerometers. To further build on past findings and to overcome the 
limitations of past research, we included several validated cognitive measures to 
assess a range of cognitive domains, namely long-term memory and learning, 
working memory, and executive functioning.  
 On the basis of past research, we predict that participants who are physically 
active will experience less cognitive domain decline than those who are inactive. We 
also predict that participants who carry the e4 allele of the APOE gene will 
experience more cognitive decline than those who do not carry this allele. In line 
with the Scaffolding Theory of Ageing and Cognition, we predict that any beneficial 
effect of physical activity on cognitive decline will be more pronounced amongst 
APOEe4 carriers. This pattern of results has been found previously amongst samples 
of cognitively normal older adults (Niti et al., 2008; Pizzie et al., 2014; Schuit et al., 
2001). This finding would suggest that physical activity helps middle aged and older 
individuals to maintain cognitive function through compensatory brain processes, 
and this may be especially so for APOEe4 carriers who may need to engage in 
greater compensatory processes in order to overcome the potentially detrimental 
effects of APOEe4 on cognitive decline.  
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Method 
Design 
 This study utilized a 2 x 2 x 4 mixed design with two between-subjects 
independent variables, physical activity status (active; inactive) and APOEe4 status 
(carrier; non-carrier), and one repeated-measures independent variable, phase of 
assessment (1; 2; 3; 4). The dependent variables were performance on tests of long-
term memory and learning, working memory, and executive functioning. 
Participants 
 This study was approved by the Tasmania Health and Medical Human 
Research Ethics Committee (approval number: H0016623; see Appendix A). Written 
informed consent was obtained from all participants (see Appendix B). Participants 
were drawn from a cohort of 513 community-dwelling middle aged and older adults 
who were participating in the Tasmanian Healthy Brain Project (THBP). The THBP 
is an ongoing longitudinal study examining the effect of an education intervention in 
later life on the prevention of age-related cognitive decline and dementia. 
Participants in the THBP experimental group partake in part-time university study 
while participants in the control group act as a reference (see Summers et al., 2013). 
The THBP has been running since 2011, with ongoing participant recruitment. 
Participants in the THBP have provided genetic samples for testing and have 
undergone annual cognitive assessments.  
 The THBP cohort is screened for dementia at each phase of cognitive 
assessment using the Mattis Dementia Rating Scale (2nd Edition). Those who show 
cognitive signs of dementia, as indicated by a score less than 132, are excluded from 
participating (Matteau et al., 2011). Other exclusion criteria comprise conditions that 
are associated with cognitive impairment, including prior head injury requiring 
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hospitalisation, multiple sclerosis, epilepsy, cerebrovascular complications such as 
stroke, aneurysm or transient ischaemic attacks, poorly controlled diabetes, poorly 
controlled hypertension or hypotension, chronic obstructive pulmonary disease, heart 
disease, current psychiatric diagnosis, and other neurological disorders such as 
cerebral palsy or spinal bifida.  
 Of those who met the THBP inclusion criteria, 53 people volunteered to take 
part in the current study. However, four participants were excluded from analysis 
because they did not have APOE genotype data, one participant was excluded 
because they scored unusually high on a scale of depression, and one participant was 
excluded because they carried the e2/e4 genotype (and the e2 and e4 alleles appear to 
have opposing effects on cognition; Small et al., 2004). The final sample consisted of 
47 participants (76.6% female; 23.4% male), aged 50-71 at baseline (M = 60.0, SD = 
5.8).  
Materials 
 Physical activity measures. 
 ActiGraph wGT3X-BT accelerometers were used to objectively record levels 
of total weekly physical activity. These devices continuously record acceleration 
forces in units of gravity and summarize this acceleration over 60-second epochs. 
The ActiGraph wGT3X-BT devices are a reliable measure of physical activity 
amongst adults in free-living conditions (Aadland & Ylvisåker, 2015). 
Accelerometers were worn during waking hours for seven days, which is an adequate 
duration to provide reliable measurements of physical activity (Aadland & Ylvisåker, 
2015). Accelerometers were worn on an elastic belt around the waist, positioned 
above the right leg as recommended by Aadland and Ylvisåker (2015). 
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 The accelerometers were accompanied by a written activity diary, which was 
completed by participants over the seven days of accelerometer wear (see appendix 
C). The activity diary detailed dates and times of accelerometer wear, times when the 
accelerometer was removed during the day, any specific activities completed for the 
purpose of exercise, and the duration of this exercise. The purpose of the activity 
diary was to record any physical activity that was completed while the accelerometer 
was not worn. 
 Demographic measures. 
 Hospital Anxiety and Depression Scale (HADS): the HADS (Zigmond & 
Snaith, 1983) was used to assess symptoms of anxiety and depression. The HADS is 
a self-report questionnaire that asks participants seven questions pertaining to anxiety 
and seven questions pertaining to depression. Participants respond along a 4-point (0-
3) response category, with higher scores indicating greater symptoms of anxiety and 
depression (Snaith, 2003). Although initially developed for use amongst inpatient 
populations, the HADS has been demonstrated as a reliable and valid measure of 
anxiety and depression amongst the general population (Bjelland, Dahl, Haug, & 
Neckelmann, 2002). Because symptoms of anxiety and depression have been 
associated with reduced cognitive test performance amongst older adults (Bierman, 
Comijs, Jonker, & Beekman, 2005), HADS score was recorded at baseline for use as 
a potential covariate. 
 Wechsler Test of Adult Reading (WTAR): the WTAR (Wechsler, 2001) was 
used to estimate pre-cognitive decline full-scale intelligence quotient (FSIQ). The 
WTAR asks participants to read aloud a list of 50 words that have irregular spelling. 
A point is afforded for each word correctly pronounced. Scores are co-normed with 
the Wechsler Adult Intelligence Scale III (WAIS-III; Wechsler, 1997) and a higher 
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score indicates greater FSIQ. The WTAR is designed to measure aspects of 
crystallised intelligence, meaning stored knowledge and skills, and thus is thought to 
be resistant to overall cognitive decline (Green et al., 2008). Because early life IQ is 
inversely associated with later life cognitive decline (Richards, Shipley, Fuhrer, & 
Wadsworth, 2004), WTAR estimated FSIQ was recorded at baseline for use as a 
potential covariate. 
 Cognitive measures. 
 A standardised neuropsychological test battery was used to assess long-term 
memory and learning, working memory, and executive functioning. The tests have 
been demonstrated as suitable for repeated testing over 12-month retest intervals 
(Lezak, Howieson, Bigler, & Tranel, 2012; Strauss, Sherman, & Spreen, 2006). 	 Long-term memory and learning tasks. 
 Rey Auditory Verbal Learning Test (RAVLT): the RAVLT (Magalhães, 
Malloy-Diniz, & Hamdan, 2012) is a valid and reliable measure of verbal memory 
and learning in which participants are presented with a list of 15 words and their 
recall of these words is tested over five successive trials. The total number of words 
recalled over the five trials is recorded, with a greater number of words indicating 
better verbal memory and learning. 
 Rey Complex Figure Test (three minute recall trial; RCFT): the RCFT 
(Berry, Allen, & Schmitt, 1991) is a valid and reliable measure of visual memory and 
learning in which participants examine a complex two-dimensional figure and are 
asked to reproduce this figure with pen and paper after a three-minute interval. 
Participants' reproductions of the figure are scored based on the accuracy of the 
details reproduced, and a higher score indicates better visual learning and memory. 	 Working memory tasks. 
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 Digit Span (DS): DS is a subtest of the WAIS-III. It assesses short-term 
memory capacity for auditory-verbal information. Participants are read a sequence of 
digits and are asked to recall them in the correct order. If recalled correctly, 
participants are presented with a longer sequence of digits. The greatest number of 
digits correctly recalled over two trials is recorded, with more digits indicating better 
working memory. 
 Letter-Number Sequencing (LNS): LNS is a subtest of the WAIS-III 
(Wechsler, 1997). It assesses the ability to manipulate auditory-verbal information in 
short-term memory. Participants are read a sequence of letters and digits (e.g. 5, A, 2 
S), and are asked to recall the letters in alphabetical order and the digits in ascending 
order (e.g. A, S, 2, 5). If recalled correctly, participants are presented with a longer 
sequence of letters and digits. The longest sequence correctly recalled over two trials 
is recorded, with a greater number of letters and digits indicating better working 
memory. As the DSP and LNS subtests of the WAIS-III were used from the outset of 
the THBP, we have continued to use these tests (rather than the updated WAIS-IV; 
Wechsler, 2008) for consistency.  	 Executive functioning tasks. 
 Controlled Oral Word Association Test (COWAT): the COWAT (Bechtoldt, 
Benton, & Fogel, 1962) is a valid and reliable measure of verbal fluency, which is 
involved in executive functioning (Ross et al., 2007). The COWAT captures 
participants' capacity to spontaneously generate words beginning with a specific 
letter. It consists of three letter trials, F, A, and S, and participants have 60 seconds 
on each trial to generate as many words beginning with the particular letter as 
possible. The total number of words generated over the three trials is recorded, with a 
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greater number of words indicating better executive functioning (Ruff, Light, Parker, 
& Levin, 1996). 
 Stroop Colour-Word Test (24-item Victoria version; VST): the VST (Stroop, 
1935) is a psychometrically strong measure of executive function (Troyer, Leach, & 
Strauss, 2009), which assesses the speed of processing and inhibitory control for 
visual information. The test consists of three trials. On the first trial, participants are 
presented with a sequence of coloured dots and are asked to name the colour of each 
dot as quickly as possible. On the second trial, participants are presented with a 
sequence of random words printed in coloured ink and are asked to name the colours 
of the ink as quickly as possible. On the third trial, participants are presented with a 
sequence of colour words printed in coloured ink. The colour words do not 
correspond to the colours of the ink. Participants are asked to name the colours of the 
ink (ignoring the colour words printed) as quickly as possible. The time difference 
(in seconds) between trial three and trial one indicates Stroop interference, and thus 
lower scores indicate better executive functioning. 
 Trail Making Test (part B; TMT): the TMTB (Reitan & Wolfson, 1985) is a 
valid and reliable measure of executive functioning (Sanchez-Cubillo et al., 2009), 
assessing divided attention on a visuo-motor task. Participants are presented with a 
piece of paper that has printed letters and numbers scattered over the page. 
Participants are asked to draw lines to connect the letters and numbers together in 
ascending order (e.g. 1-A-2-B-3-C-4-D and so on) as quickly as possible. 
Performance on the TMTB is measured in seconds, and thus lower scores indicate 
better executive functioning. 
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Procedure 
 To recruit participants, an invitation to participate was placed in the THBP 
newsletter, which was emailed or mailed to each participant depending on participant 
preference. Individual invitations to participate were also emailed or mailed to 
participants (see Appendix D). 
 To measure total weekly levels of physical activity, participants were sent an 
accelerometer, written instructions, seven-day activity diary, and reply-paid postage 
bag. Participants were asked to wear the accelerometer during waking hours for 
seven consecutive days. As the accelerometers are not waterproof, participants 
removed devices for water activities such as swimming and showering. After seven 
days, participants returned the accelerometer along with the signed consent form and 
activity diary via post.  
 Using Access computer software, we applied the Freedson equation to 
translate raw acceleration data into weekly minutes spent in light, moderate, and 
vigorous physical activity, based on metabolic equivalent minute (MET) values 
(Freedson, Melanson, & Sirard, 1998). Any physical activity that was completed 
while the accelerometer was not worn was compared to the 2011 Compendium of 
Physical Activities (Ainsworth et al., 2011) to estimate MET values. Total weekly 
minutes spent in moderate and vigorous physical activity were then compared to the 
World Health Organization's Global Recommendations on Physical Activity for 
Health (2010). Participants who met or exceeded the recommended weekly target of 
150 minutes of moderate physical activity or 75 minutes of vigorous physical activity 
(or an equivalent combination of the two) were grouped as active. Participants who 
did not reach this target were grouped as inactive. 
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 Participants were also asked to complete the Incidental and Planned Exercise 
Questionnaire (weekly average version; IPEQ-WA; Delbaere, Hauer, & Lord, 2010), 
and the Historical Leisure Activities Questionnaire (HLAQ; Kriska et al., 1988). The 
IPEQ-WA is a self-report questionnaire that asks participants to indicate their typical 
weekly physical activity for the past three months. The HLAQ is a self-report 
questionnaire that asks participants to indicate the frequency and duration with which 
they engaged in a range of activities over their lifetime. The questionnaires were 
completed via Survey Monkey or via mail-out, depending on participant preference. 
Responses to these questionnaires are beyond the scope of this study and therefore 
will not be discussed.  
 Participants provided salivary samples to the THBP team for DNA extraction. 
To determine APOE genotype, PCR analysis was conducted as described by 
Donohoe, Salomäki, Lehtimäki, Pulkki, and Kairisto (1999). Participants were 
grouped as APOEe4 carriers (e3/e4; e4/e4 genotypes) and non-APOEe4 carriers 
(e2/e2; e2/e3; e3/e3 genotypes). There is evidence to suggest that the e2 allele of the 
APOE gene is protective against age-related cognitive decline (Small et al., 2004). 
Therefore, to eliminate the potentially confounding influence of APOEe2 on 
cognitive decline, we excluded participants with the e2/e4 genotype from analysis. 
 Administration of the neuropsychological test battery occurred annually 
through the THBP. Assessments that took place at baseline and over the proceeding 
three years were used to examine cognitive test performance across each assessment 
phase. Participants consented to have their genetic data and cognitive data released to 
us as part of the informed consent process, and data was de-identified by the THBP 
project manager prior to its release. 
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Data Screening and Analysis  
 All analyses were conducted using SPSS version 21. Initially, 53 participants 
took part in the study. However, four participants were excluded because they did not 
have APOE genotype data, and one participant was excluded because they carried 
the e2/e4 genotype. 
 Continuous demographic variables (age; body mass index; years of 
education; HADS anxiety; HADS depression; WTAR estimated FSIQ) were tested at 
baseline for skew and outliers. There was one extreme outlier on the HADS 
depression sub-scale that was more than four standard deviations above the mean. 
Because depression has a global negative effect on cognitive test performance 
(Bierman, Comijs, Jonker, & Beekman, 2005), we excluded this participant from 
analysis. After excluding data from this participant, all demographic variables were 
normally distributed. Thus, a total of 47 participants were included in the final 
analyses. 
 Continuous dependent variables (RAVLT score; RCFT score; DS score; LNS 
score; COWAT score; VST interference; and TMTB time) were tested at each 
assessment phase for outliers and skew. On at least one assessment phase, there were 
outliers on RAVLT score, RCFT score, LNS score, VST interference, and TMTB 
time. On at least one assessment phase, RAVLT scores and RCFT score were 
negatively skewed, and VST interference and TMTB time were positively skewed. 
Square-root transformations were performed to control for skew. However, as these 
transformations did not alter the results and maximum likelihood estimation is robust 
to non-normality (Enders, 2001), final analyses were conducted using the 
untransformed data.  
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 We compared APOE genotype proportions of the sample to estimated 
genotype proportions of the worldwide population (Zannis et al., 1993), and the 
sample distribution did not significantly differ from a Hardy-Weinberg equilibrium, 
χ2(5) = 8.60, p = .126, V = .43 (Table 1).  Differences in demographic characteristics 
between the four physical activity/e4 groups were also checked using chi-square tests 
of independence for categorical variables and one-way analyses of variance 
(ANOVAs) for continuous variables. There were no significant differences between 
groups (Table 2).  
 
Table 1 
Frequency of APOE Genotypes Found in the Worldwide Population and in the 
Current Sample 
Frequency e2/e2 e2/e3 e2/e4 e3/e3 e3/e4 e4/e4 
Estimated worldwide (%) 1.2 15.8 3.7 51.8 24.5 2.9 
Sample (%) 0.0 6.4 0.0 59.6 34.0 0.0 
  
 
 As some participants had missing cognitive data on one or more assessment 
phase, we used full information maximum likelihood ANOVAs to accommodate for 
missing values (Enders, 2010). We conducted a series of three-way mixed ANOVAS 
to test for interaction effects between physical activity status (active; inactive), 
APOEe4 status (carrier; non-carrier), and assessment phase (1; 2; 3; 4) on 
performance on each of the cognitive tests. 
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 Table 2 
Demographic Characteristics of Active and Inactive Groups by APOEe4 Carrier 
Status 
 Active  Inactive   
Characteristic 
e4 
carriers  
(N = 
13) 
Non-e4 
carriers 
(N = 
27) 
 e4 
carriers 
(N = 3) 
Non-e4 
carriers 
(N = 4) 
χ2/F (df) p 
Sex, n (%)        
 Female 10 (76.9) 
20 
(74.1) 
 3 
(100.0) 3 (75.0) 
χ2(3) = 
1.02 .797 
 Male 3 (23.1) 7 (25.9)  0 (0.0) 1 (25.0)   
THBP group, n (%)        
 Experimental 9 (69.2) 23 (85.2) 
 1 (33.3) 3 (75.0) χ
2(3) = 
4.64 .200 
 Control 4 (30.8) 4 (14.8)  2 (66.7) 1 (25.0)   
Age, M (SD) 60.9 (5.1) 
58.5 
(5.6) 
 63.0 
(9.5) 
64.0 
(5.4) 
F(3, 43) 
= 1.61 .202 
BMI, M (SD)* 25.2 (3.8) 
25.5 
(4.6) 
 19.0 
(0.3) 
29.0 
(1.6) 
F(3, 38) 
= 2.31 .092 
Years of education, 
M (SD) 
14.0 
(3.0) 
14.4 
(2.4) 
 12.7 
(1.5) 
15.8 
(3.8) 
F(3, 43) 
= 0.83 .483 
HADS depression, 
M (SD) 
2.4 
(1.6) 
1.7 
(1.5) 
 3.0 
(2.0) 
1.3 
(1.0) 
F(3, 43) 
= 1.38 .263 
HADS anxiety, M 
(SD) 
5.2 
(2.3) 
5.2 
(2.7) 
 5.0 
(2.6) 
4.3 
(2.2) 
F(3, 43) 
= 0.18 .912 
WTAR estimated 
FSIQ, M (SD) 
111.0 
(6.4) 
112.9 
(3.9) 
 110.3 
(7.1) 
114.3 
(4.5) 
F(3, 43) 
= 0.79 .506 
Note. THBP = Tasmanian Healthy Brain Project; BMI = body mass index; HADS = 
Hospital Anxiety and Depression Scale; WTAR = Wechsler Test of Adult Reading; 
FSIQ = full-scale intelligence quotient. 
*N(active e4 carriers) = 11; N(active non-e4 carriers) = 26; N(inactive e4 carriers) = 
2; N(inactive non-e4 carriers) = 3. Five participants did not have BMI data. 
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Results  
 All effects and differences are reported as significant at p <.05 unless 
otherwise stated.  
Long-term Memory and Learning 
 For both measures of long-term memory and learning, there were no 
significant main effects of physical activity status or APOEe4 status, indicating that 
overall RAVLT score and RCFT score was similar between each of the physical 
activity groups and each of the APOEe4 groups. There was a significant main effect 
of assessment phase on RAVLT score. Pairwise comparisons revealed that RAVLT 
score increased from phase 2 to phase 3 (p = .013, g = 0.34), and this was a small 
effect. However, this difference was not significant after considering a Bonferroni-
adjusted p-value of .008 to control for Type I error. There was also a significant main 
effect of assessment phase on RCFT score. Pairwise comparisons revealed that 
RCFT score significantly increased from phase 1 to phase 2 (p <.001, g = 0.60), and 
again from phase 2 to phase 3 (p = <.001, g = 0.54), using a Bonferroni-adjusted p-
value of .008, and these were medium effects. These improved performances over 
phases of assessment indicate possible practice and learning effects. Mean RAVLT 
scores and RCFT scores at each assessment phase are shown in Table 3. 
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Table 3 
Mean Scores on the Rey Auditory Verbal Learning Test and Rey Complex Figure 
Test at Each Assessment Phase 
 
  RAVLT  RCFT 
Phase N M 95% CI  M 95% CI 
1 47 52.4 [49.2, 55.6]  22.3 [20.2, 24.4] 
2 44 50.0 [46.8, 53.2]  26.7 [24.5, 28.8] 
3 45 53.8 [50.4, 57.2]  30.6 [28.3, 32.8] 
4 45 53.6 [50.3, 56.9]  31.1 [28.9, 33.3] 
Note. RAVLT = Rey Auditory Verbal Learning Test; RCFT = Rey Complex Figure 
Test; CI = confidence interval. 
 
 
 For both measures of long-term memory and learning, there were no 
significant two-way interactions between physical activity status and assessment 
phase, or APOEe4 status and assessment phase, indicating that the effects of 
assessment phase on RAVLT score and on RCFT score were not influenced by 
whether participants were active or inactive, or whether or not they carried the 
APOEe4 allele. There were also no significant two-way interactions between 
physical activity status and APOEe4 status. Finally, there were no significant three-
way interactions between physical activity status, APOEe4 status, and assessment 
phase. All estimated fixed effects for the ANOVA results are shown in Table 4. 
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Table 4 
Fixed Effects Estimates for Analysis of Variance Results for Measures of Long-term 
Memory and Learning 
 
Variable F (df within, error) p 
RAVLT   
 Physical activity status 2.82 (1, 47.84) .100 
 ApoEe4 status 0.07 (1, 47.84) .791 
 Assessment phase 2.89 (3, 135.14) .039 
 Physical activity * phase 0.67, (3, 135.14) .574 
 ApoEe4 * phase 1.17 (3, 135.14) .323 
 Physical activity * ApoEe4 0.14 (1, 47.84) .713 
 Physical activity * ApoEe4 * phase 2.46 (3, 135.14) .065 
RCFT   
 Physical activity status 0.65 (1, 47.28) .423 
 ApoEe4 status 1.20 (1, 47.28) .280 
 Assessment phase 30.92 (3, 134.69) <.001 
 Physical activity * phase 0.80 (3, 134.69) .494 
 ApoEe4 * phase 1.13 (3, 134.69) .338 
 Physical activity * ApoEe4 2.26 (1, 47.28) .139 
 Physical activity * ApoEe4 * phase 0.28 (3, 134.69) .840 
Note. Significant effects at the p <.05 level are in boldface. RAVLT = Rey Auditory 
Verbal Learning Test; RCFT = Rey Complex Figure Test. 
 
Working Memory 
 For both measures of working memory, there were no significant main effects 
of physical activity status or APOEe4 status, indicating that overall DS score and 
LNS score was similar between each of the physical activity groups and each of the 
APOEe4 groups. There was a significant main effect of assessment phase on DS 
score. But, there was no significant main effect of assessment phase on LNS score, 
indicating that LNS score was similar at each phase of assessment. 
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 There was a significant two-way interaction effect between physical activity 
status and assessment phase on DS score. Pairwise comparisons revealed that for 
active participants, DS score was greater at phase 4 than at phase 3 (p = .020, g = 
0.28), at phase 2 (p = .021, g = 0.29), and at phase 1 (p = .007, g = 0.33), and these 
were small effects. However, these comparisons were not significant after 
considering a Bonferroni-adjusted p-value of .004. For inactive participants, DS 
score decreased from phase 1 to phase 2 (p = .002, g = 0.90), which was a large 
effect, and increased from phase 2 to phase 4 (p = .022, g = 0.70), which was a 
medium effect. However, only the phase 1 vs. phase 2 comparison was significant 
after using a Bonferroni-adjusted p-value of .004. Mean DS scores at each 
assessment phase for active and inactive participants are shown in Figure 1.  
 
 
Figure 1. Mean Digit Span score at each assessment phase for active and inactive 
participants. Error bars represent 95% confidence intervals. Points are offset 
horizontally so that error bars are visible. 
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 There was no significant two-way interaction effect between physical activity 
status and assessment phase on LNS score. For both measures of working memory, 
there were no significant two-way interactions between APOEe4 status and 
assessment phase, or between physical activity status and APOEe4 status. Finally, 
there were no significant three-way interactions between physical activity status, 
APOEe4 status, and assessment phase, indicating that the interaction between 
physical activity and assessment phase on DS score did not significantly differ 
between APOEe4 carriers and non-APOEe4 carriers. All estimated fixed effects for 
the ANOVA results are shown in Table 5. 
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Table 5 
Fixed Effects Estimates for Analysis of Variance Results for Measures of Working 
Memory 
 
Variable F (df within, error) p 
DS   
 Physical activity status 0.38 (1, 47.37) .543 
 ApoEe4 status 0.31 (1, 47.37) .580 
 Assessment phase 3.83 (3, 134.57) .011 
 Physical activity * phase 3.17 (3, 134.57) .026 
 ApoEe4 * phase 0.30 (3, 134.57) .825 
 Physical activity * ApoEe4 0.15 (1, 47.37) .701 
 Physical activity * ApoEe4 * phase 0.60 (3, 134.57) .616 
LNS   
 Physical activity status 0.34 (1, 47.57) .565 
 ApoEe4 status 1.27 (1, 47.57) .266 
 Assessment phase 0.27 (3, 134.82) .844 
 Physical activity * phase 0.17 (3, 134.82) .916 
 ApoEe4 * phase 0.76 (3, 134.82) .520 
 Physical activity * ApoEe4 0.03 (1, 47.57) .874 
 Physical activity * ApoEe4 * phase 0.27 (3, 134.82) .846 
Note. Significant effects at the p <.05 level are in boldface. DS = Digit Span; LNS = 
Letter-Number Sequencing. 
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Executive Functioning 
 For all measures of executive functioning, there were no significant main 
effects of physical activity status or APOEe4 status, indicating that overall COWAT 
score, VST interference, and TMTB time were similar between each of the physical 
activity groups and each of the APOEe4 groups. There was a significant main effect 
of assessment phase on VST interference. But, there were no significant main effects 
of assessment phase on COWAT score or TMTB time, indicating that COWAT score 
and TMTB time was similar at each phase of assessment. 
 There was a significant two-way interaction effect between physical activity 
status and assessment phase on VST interference. Pairwise comparisons revealed that 
for active participants, VST interference significantly decreased between phase 1 and 
phase 4 (p = .003, g = 0.45), using a Bonferroni-adjusted p-value of .004, and this 
was a small to medium effect. For inactive participants, VST interference was 
significantly greater at phase 3 than at phase 1 (p = .016, g = 1.02), at phase 2 (p = 
.005, g = 1.21), and at phase 4 (p = .010, g = 1.15). Although these were large 
effects, these comparisons were not significant after using a Bonferroni-adjusted p-
value of .004. Mean VST interference at each assessment phase for active and 
inactive participants are shown in Figure 2. 
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Figure 2. Mean VST interference at each assessment phase for active and inactive 
participants. Error bars represent 95% confidence intervals. Points are offset 
horizontally so that error bars are visible. 
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Table 6 
Fixed Effects Estimates for Analysis of Variance Results for Measures of Executive 
Functioning 
 
Variable F (df within, error) p 
COWAT   
 Physical activity status 0.57 (1, 47.80) .454 
 ApoEe4 status 0.30 (1, 47.80) .587 
 Assessment phase 2.05 (3, 135) .110 
 Physical activity * phase 0.92 (3, 135) .433 
 ApoEe4 * phase 0.83 (3, 135) .481 
 Physical activity * ApoEe4 .001 (1, 47.80) .976 
 Physical activity * ApoEe4 * phase 1.08 (3, 135) .361 
VST   
 Physical activity status 2.27 (1, 47.38) .139 
 ApoEe4 status 3.77 (1, 47.38) .058 
 Assessment phase 3.21 (3, 134.93) .025 
 Physical activity * phase 3.61 (3, 134.93) .015 
 ApoEe4 * phase 0.51 (3, 134.93) .674 
 Physical activity * ApoEe4 3.67 (1, 47.38) .061 
 Physical activity * ApoEe4 * phase 0.30 (3, 134.93) .827 
TMTB   
 Physical activity status 0.04 (1, 47.33) .844 
 ApoEe4 status 0.01 (1, 47.33) .923 
 Assessment phase 1.70 (3, 134.55) .171 
 Physical activity * phase 0.80 (3, 134.55) .496 
 ApoEe4 * phase 0.41 (3, 134.55) .746 
 Physical activity * ApoEe4 0.03 (1, 47.33) .872 
 Physical activity * ApoEe4 * phase 0.56 (3, 134.55) .641 
Note. Significant effects at the p <.05 level are in boldface. COWAT = Controlled 
Oral Word Association Test; VST = Victoria Stroop Test; TMTB = Trail Making 
Test (part B). 
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Discussion 
 The present study was designed to examine the influence of objectively 
measured physical activity and APOEe4 on age-related cognitive decline amongst 
cognitively normal middle aged and older adults. We predicted that participants who 
were physically active would experience less cognitive decline than those who were 
inactive, and that participants who carried APOEe4 would experience more cognitive 
decline than those who did not carry this allele. On the basis of past research (Niti et 
al., 2008; Pizzie et al., 2014; Schuit et al., 2001) and the Scaffolding Theory of 
Ageing and Cognition, we also predicted that any beneficial effect of physical 
activity on cognitive decline would be more pronounced amongst APOEe4 carriers 
than non-APOEe4 carriers. 
Present Findings  
 Results of the present study revealed significant interaction effects between 
physical activity and assessment phase on DS and VST performance. Results 
revealed that inactive participants showed some significant short-term performance 
decline on DS, and active participants showed some significant performance 
improvement on the VST. Generally, active participants' performance on the DS and 
VST remained steady or improved across each phase of assessment, while inactive 
participants' performance tended to fluctuate. This general pattern of results is 
consistent with our hypothesis that active participants would experience less 
cognitive decline than inactive participants. However, these changes in cognitive 
performance were not consistent across every phase of assessment, and the 
interaction was not present for every test of working memory and of executive 
functioning, which is what we would expect if there were a true consistent effect of 
physical activity on these domains of cognition. Thus, results suggest that physical 
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activity does not have a consistent long-term effect on normal age-related cognitive 
decline.  
 This finding is inconsistent with previous research, which shows a consistent 
protective effect for all levels of physical activity on overall cognitive decline (e.g. 
Best et al., 2017; Sofi et al., 2010). Previous research also shows that physical 
activity seems to be particularly beneficial to executive functioning and processing 
speed amongst groups of cognitively normal individuals (Netz et al., 2011; Wilbur et 
al., 2012). This finding was not replicated in the present study, with results showing 
no consistent effect of physical activity across the three tests of executive 
functioning. Few reported studies show no significant effect of physical activity on 
neurocognitive health (Gidicsin et al., 2015). However, this may be a result of 
publication bias, meaning that statistically significant results are more likely to be 
published than non-significant results (Dick et al., 2015). 
 Across all cognitive domains, there were no significant interaction effects 
between APOEe4 status and assessment phase. This finding is inconsistent with our 
hypothesis that APOEe4 carriers would experience more cognitive decline than non-
APOEe4 carriers. This suggests that APOEe4 does not influence age-related 
cognitive decline amongst healthy middle-aged and older adults.  
 Previous research shows inconsistent findings. Some studies suggest that the 
presence of APOEe4 has a detrimental effect on cognitive decline in normal ageing 
(Caselli et al., 2004; Caselli et al., 2007; Wisdom, Callahan, & Hawkins, 2011). 
However, this influence has been relatively small and specific to the domains of 
episodic memory and executive functioning (Small et al., 2004). Other studies have 
reported no independent effect of APOEe4 on cognition amongst healthy older adults 
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(Foster et al., 2013; Ward et al., 2014; Quintas et al., 2014), consistent with findings 
of the present study. 
 Across all cognitive domains, there were no significant interactions between 
physical activity status, e4-carrier status, and phase of cognitive assessment. This 
finding is inconsistent with our hypothesis that any beneficial effect of physical 
activity on cognitive decline would be more pronounced amongst APOEe4 carriers 
than non-APOEe4 carriers. This suggests that the combination of physical activity 
and presence or absence of APOEe4 does not influence age-related cognitive decline 
amongst healthy middle-aged and older adults. 
 Past research has typically found significant interactions between physical 
activity and APOEe4. However, the nature of these interactions has been inconsistent 
and effect sizes have often been small (Wisdom et al., 2011). Some studies show that 
physical activity is associated with reduced decline in cognitive functioning, and that 
this is effect is more pronounced for APOEe4 carriers (Niti et al., 2008; Pizzie et al., 
2014; Schuit et al., 2001; Thibeau et al., 2017; Woodward et al., 2012). However, 
other studies show that the benefits of physical activity to later-life cognition are 
more pronounced for non-APOEe4 carriers (Obisesan et al., 2012; Podewils et al., 
2005). Both of these patterns of results are inconsistent with the findings of the 
present study. Few reported studies show no significant interaction effect between 
physical activity and APOEe4 on cognitive decline.  
Possible Explanations 
 Previous research has largely focused on the influence of physical activity 
and APOEe4 on pathological cognitive decline. A meta-analysis by Guure, Ibrahim, 
Adam, and Said (2017) found that the protective effects of physical activity are much 
larger for dementia and Alzheimer's disease than for non-pathological cognitive 
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decline. Additionally, APOEe4 has been demonstrated a major risk factor for 
Alzheimer's disease (Farrer et al., 1997), but the effect of APOEe4 on normal age-
related cognitive decline has been inconsistent and effect sizes have often been small 
(Small et al., 2004). These inconsistent results may be because previous studies may 
have included pre-clinical dementia cases in their samples (Small et al., 2004). It is 
possible that findings of the present study showed no consistent effects of physical 
activity and APOEe4 on normal age-related cognitive decline because these factors 
only influence pathological cognitive decline, and are not important to non-clinical 
decline. 
 Another possible explanation of the present findings is that there may be a 
dose-response relationship between APOEe4 and cognitive decline. There is some 
evidence to suggest that APOEe4 has a dose-response relationship with cognitive 
decline in Alzheimer's disease, with APOEe4 homozygotes experiencing a greater 
rate of disease-related decline than APOEe4 heterozygotes (Martins et al., 2005). It is 
possible that this dose-response relationship is also present in normal ageing. Indeed, 
Etnier et al. (2007) found that aerobic fitness was significantly associated with 
memory performance amongst APOEe4 homozygotes, but not amongst APOEe4 
heterozygotes, in a healthy sample of older women. Due to the relatively low 
population frequency of APOEe4 (17%; Zannis et al., 1993), we were only able to 
dichotomise participants into APOEe4 carriers and non-APOEe4 carriers, and indeed 
did not have any APOEe4 homozygotes in our sample. Therefore, we were unable to 
directly examine the possibility of an APOEe4 allele dose-response relationship. It is 
possible that there is an interaction between physical activity and the APOEe4 allele 
(consistent with previous research), but that this interaction is only apparent for those 
at greatest genetic risk of increased cognitive decline. Additionally, all participants 
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were aged 50-71 years and our sample did not include any individuals in the older 
stages of late adulthood. A meta-analysis by Wisdom et al. (2017) found that the 
detrimental effects of the e4 allele increase with age. It is possible that we did not 
find any significant effects of the e4 allele amongst our sample because any potential 
effects of the e4 allele may not become apparent until older age. 
 Another possible explanation of our findings is that the demographic 
characteristics of our sample may have been sufficiently protective of cognitive 
decline, so that physical activity and APOEe4 had no additional effect. For example, 
Rovio et al. (2005) found that physical activity at midlife was associated with a 
reduced risk of dementia and Alzheimer’s disease in later life, especially for 
APOEe4 carriers. However, this interaction between physical activity andAPOEe4 
was not significant after researchers controlled for a range of other factors such as 
education and medical history.  
 In the present study, participants were excluded if they had a history of 
medical issues associated with cognitive impairment, and our final sample consisted 
of participants who had, on average, a high level of education, and above average 
estimated FSIQ (see Table 2). It is also possible that there was a participation bias, 
meaning that participants who volunteered to take part in the study may have had 
higher levels of motivation and may have been more engaged with their community. 
Education, FSIQ, and social engagement have each been positively associated with 
greater cognitive function in later life (Karama et al., 2014; Krueger et al., 2009; Lee, 
Kawachi, Berkman, & Grodstein, 2003). According to the Scaffolding Theory of 
Ageing and Cognition, lifestyle factors such as learning and social engagement 
enhance neural scaffolding, which in turn helps to maintain cognitive function in 
later life (Reuter-Lorenz & Park, 2014). Thus, it is possible that the cognitive health 
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of our sample was sufficiently high that any additional effects of physical activity 
and the e4 allele on cognition were not evident.  
 Furthermore, high levels of physical activity tend to coincide with other 
protective factors. For example, physical activity is associated with higher levels of 
education, younger age, absence of chronic health conditions, and lower levels of 
psychological distress amongst older adults (Kaplan, Newsom, McFarland, & Lu, 
2001). Thus, it is possible that the independent association of physical activity with 
later-life cognition is weaker than previously reported. The previously reported 
effects of physical activity on cognition may have been a result of these potentially 
confounding factors rather than any physiological influence of physical activity 
itself. In the present study, it is possible that we did not find any consistent effects of 
physical activity on cognitive decline because all participants were similar in age, 
level of education, estimated FSIQ, and levels of reported anxiety and depression.   
 In terms of the significant interaction effects between physical activity and 
assessment phase on DS and VST performance, one possible explanation of these 
findings is the small size of our inactive group. Of 47 participants, only 7 were 
grouped as inactive. This means that the cognitive scores of one or two inactive 
participants may have exerted a strong influence on the overall mean of the group, 
and may explain why the inactive group showed an inconsistent pattern of cognitive 
performance on DS and VST.  
 Alternatively, another potential explanation is that physical activity may 
indirectly benefit cognitive test performance through its positive influence on the 
ability to allocate and monitor attention resources (Hillman, Belopolsky, Snook, 
Kramer, & McAuley, 2004). Inactive individuals may experience difficulty paying 
sustained attention to cognitive tasks, leading them to show an inconsistent pattern of 
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performance across each phase of assessment and across each cognitive test. 
Although we would expect fluctuations in attention to be averaged across 
participants, this may not have occurred due to the small size of our inactive group. 
Furthermore, as attention decreases with age (Sofi et al., 2010), it is possible that the 
inconsistent pattern of performance on DS and VST demonstrated by the inactive 
group is reflective of age-related decline in attentional processes. 
Limitations  
 Findings should be interpreted in light of the study's limitations. Firstly, to 
measure cognitive decline, we used data from cognitive assessments that had 
previously taken place. However, we categorized participants as active or inactive 
based on their present level of physical activity. It is possible that participants' 
current levels of physical activity were not representative of their prior levels of 
activity. Some participants in the active group may have been inactive at the time of 
cognitive assessment, although it is more likely that some participants who were 
classed as inactive may have been active at the time of cognitive assessment, as 
physical activity typically decreases with age (Kaplan et al., 2001). If this were the 
case, any possible differences in cognitive decline between the active and inactive 
groups would be minimized in the current sample. This may explain why results did 
not show any consistent long-term effects of physical activity.  
 It is also noteworthy that over 80% of participants in the present sample were 
grouped as physically active. However, less than 45% of the general Australian 
population aged over 50 years engages in the recommended level of physical activity 
(Australian Bureau of Statistics, 2013). Therefore, the high number of physically 
active participants in our sample is atypical. We used accelerometers to objectively 
record physical activity, thus eliminating the potential for recall bias that is 
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associated with self-report measures. However, it is possible that participants may 
have increased their physical activity levels throughout the duration of the study 
because they were aware that their activity levels were being recorded. Additionally, 
some participants may have recently increased or decreased their physical activity in 
response to subjective changes in their cognitive function. Future research could 
overcome this limitation by including a measure of physical activity at each phase of 
cognitive assessment, or by including a physical activity intervention for more 
accurate groupings of active and inactive participants. 
 Related to the aforementioned point, this study is further limited by its small 
sample size and uneven group sizes, which may have compromised the robustness of 
ANOVAs (Dick et al., 2015; Field, 2018). Furthermore, due to the small sample size, 
our study may not have had adequate power to detect a true interaction between 
physical activity and APOEe4. This is a common problem in genetic research as 
population frequencies of the allele in question are often low (Dick et al., 2015). 
Additionally, participants showed little variation in demographic variables, and were 
screened for any medical conditions associated with cognitive impairment. This may 
have been compounded further by participation bias, as our participants were not 
randomly selected from the wider population. As a result, our sample may not be 
representative of the general population.  
 A possible limitation of this study is that we included physical activity as a 
categorical variable. Those who engaged in the recommended amount of moderate 
and vigorous activity were classed as active, thereby aligning with the World Health 
Organization's physical activity guidelines. However, it is possible that any benefits 
of physical activity to cognition are only evident at high levels of activity. Middleton 
et al. (2011) found a dose-response relationship between total daily energy 
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expenditure from activity and incidence of cognitive impairment, such that greater 
energy expenditure was associated with a reduced incidence of cognitive impairment. 
It is possible that there is a similar dose-response relationship between physical 
activity and normal age-related cognitive decline that could not be detected in our 
dichotomized sample. Future research could overcome this limitation by measuring 
physical activity along a continuous scale, or by grouping participants into low, 
moderate, and high physical activity groups for a more nuanced exploration of the 
effect of physical activity. 
Contributions 
 This study has made some notable contributions to the research field of age-
related cognitive decline. To our knowledge, this is the first study of physical 
activity, APOEe4, and cognitive decline to employ the use of accelerometers. Past 
studies have relied on self-report questionnaires (e.g. Niti et al., 2008; Obisesan et 
al., 2012; Schuit et al., 2001), or have measured participants' physical fitness to 
indirectly estimate level of physical activity (e.g. Etnier et al., 2007). Accelerometers 
offer benefits over both of these methods because they provide a direct objective 
measure of physical activity, and can be used to record participants' behaviour in 
free-living conditions. Accelerometers also capture total daily physical activity, not 
only physical activity from exercise. This is important because non-exercise physical 
activity is an important contributor to physical health (Levine, 2007; Matthews et al., 
2007), and therefore it is probable that it is beneficial to neurocognitive health as 
well.  
 When using accelerometers to examine the influence of physical activity on 
cognition it is important to be mindful that the accelerometers also capture work-
related physical activity. Manual labour-based work has been associated with a lower 
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level of educational attainment (Rovio et al., 2007). Thus, studies using 
accelerometers to examine the influence of physical activity on cognition should be 
mindful of the potentially confounding influence of education. However, in the 
present study the active and inactive groups reported a similar level of education. 
Thus, the use of accelerometers to objectively measure physical activity is a 
particular strength of this study. 
 Furthermore, the majority of past research into later-life cognition has 
focused on the pathological cognitive decline present in dementia and Alzheimer's 
disease. However, identifying factors that may be associated with age-related 
cognitive decline, prior to clinically significant cognitive impairment, may be more 
effective at reducing the burden of dementia and Alzheimer's disease than current 
approaches. Additionally, normal age-related cognitive decline can be distressing for 
individuals to experience. An understanding of the modifiable factors that may be 
associated with cognitive decline could be of benefit to older adults who wish to 
delay or slow normal age-related cognitive decline. Thus, this study has contributed 
to the field of cognition research by examining normal, non-pathological cognitive 
decline. 
 Finally, previous studies have either relied on the MMSE to assess global 
cognitive decline (e.g. Obisesan et al., 2012; Podewils et al., 2005), or have 
examined only one aspect of cognition (e.g. Thibeau et al., 2017; Etnier et al., 2007). 
However, some cognitive domains may be more influenced by physical activity and 
APOEe4 than others. Furthermore, many previous longitudinal studies have only 
included one follow-up cognitive assessment and follow-up periods have often been 
short, ranging from one to three years (Niti et al., 2008; Schuit et al., 2001; 
Woodward et al., 2012). To overcome these limitations, we chose to assess 
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performance on a range of cognitive tests annually over four years to provide a 
comprehensive and in-depth assessment of cognitive decline. Thus, the longitudinal 
and domain-specific measurement of cognitive decline is a particular strength of this 
study. 
Future Directions 
 Future research would benefit from investigating the influence of lifetime 
physical activity on age-related cognitive decline, and potential interactions with 
APOEe4. The present study examined only middle-aged and older adults' current 
levels of physical activity, and few studies have examined the influence of lifetime 
physical activity on late-life cognition and its interaction with APOEe4. As normal 
age-related cognitive decline begins prior to the age of 60 (Salthouse, 2009) and 
memory decline can become accelerated for APOEe4 carriers from as early as 50 
years (Caselli et al., 2004), it is probable that early life physical activity is an 
important determinant of later-life cognitive function.  
  Indeed, Chang et al. (2010) found that being physically active during mid-
life is associated with better executive functioning, a faster speed of processing, and 
better memory in later-life, compared to being inactive. Additionally, Middleton, 
Barnes, Lui, and Yaffe (2010) found that women who reported being physically 
active at any point over their lifetime had a lower likelihood of cognitive impairment 
in late-life, compared to those who were inactive. Interestingly, teenage physical 
activity was most strongly associated with reduced odds of late-life cognitive 
impairment than physical activity during any other age. Examining whether lifetime 
physical activity interacts with APOEe4 to influence age-related cognitive decline 
would be beneficial. 
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 Future research would also benefit from examining whether different types of 
physical activity have differential effects on cognition. In the present study, we 
measured only total daily physical activity, and few studies have examined the 
influence of different types of activity on cognition. One study conducted by Bossers 
et al. (2015) showed that aerobic training coupled with strength training was more 
effective than aerobic-only training at reducing cognitive decline in those with 
dementia. It is possible that strength training in particular may be beneficial in 
reducing normal age-related cognitive decline. Furthermore, it is possible that some 
of the previously reported benefits of physical activity were attributable to the social 
engagement and cognitive stimulation that is often coupled with physical activity, 
rather than the physiological influence of physical activity itself. Future research 
could investigate this possibility by employing a physical activity intervention, where 
groups of participants attend weekly aerobic, strength, and flexibility classes, and a 
control group attends weekly social gatherings.  
Conclusion 
 The present study was designed to examine the influence of physical activity 
and APOEe4 on age-related cognitive decline amongst a sample of middle-aged and 
older adults. Understanding the factors that may influence age-related cognitive 
decline may be beneficial in identifying areas to implement potential prevention 
interventions. 
 Past research in this area has been limited by its use of self-report 
questionnaires to measure physical activity, by its focus on pathological cognitive 
decline, and by its use of the MMSE to assess cognitive function. The present study 
overcame these limitations by using accelerometers to objectively record 
participants' levels of total weekly physical activity, by assessing cognitive decline 
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amongst a cognitively normal sample, and by using a range of validated tests to 
assess the cognitive domains of long-term memory and learning, working memory, 
and executive functioning. However, this study was limited by the delay between 
administering cognitive assessments and physical activity assessments, by the 
relatively small sample size and uneven group sizes, and possibly by its categorical 
measure of physical activity.  
 In closing, findings indicated that physical activity, APOEe4, or 
combinations of the two do not influence normal age-related cognitive decline. This 
suggests that physical activity may not reduce normal age-related cognitive decline, 
and that APOEe4 does not increase normal age-related cognitive decline. However, it 
is also possible that any detrimental effects of APOEe4 on normal cognitive decline 
may only be evident for individuals who carry two copies of the e4 allele, or that any 
previously reported benefits of physical activity may have been attributable to other 
protective factors that tend to coincide with high levels of physical activity. Future 
research would benefit from examining the influence of lifetime physical activity on 
age-related cognitive decline, and from examining whether different types of 
physical activity have differential effects on age-related cognitive decline. 
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Appendix A: Tasmania Human Research Ethics Committee Approval 	
 
Dear Ms Padgett, 
 
Ethics Ref: H0016623 
Title: Exploring the Roles of Physical Activity and Genetic Predictors on Cognition in 
Older Adults 
 
This email is to confirm that the following amendment was approved by the Chair of 
the Tasmania Health and Medical Human Research Ethics Committee on 18/5/2018: 
 
Amendment Newsletter, Email and Mail out invitations 
Amendment Accelerometer Instructions  
Consent Form PICF PA Amended 110418 
Amendment add an additional objective measure of physical activity 
Amendment undertake another recruitment drive 
 
All committees operating under the Human Research Ethics Committee (Tasmania) 
Network are registered and required to comply with the National Statement on 
Ethical Conduct in Human Research (NHMRC 2007). 
 
This email constitutes official approval. If your circumstances require a formal letter 
of amendment approval, please let us know. 
 
Should you have any queries please do not hesitate to contact me. 
 
Kind regards 
 
Lauren Di Palma  
 
-- 
Executive Officer - Ethics 
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Appendix B: Participant Information Sheet and Consent Form 	
	 	
Participant	Information	Sheet	[1.2]	[11th	April	2018]		
Exploring the Roles of Physical Activity and Genetic Predictors on Cognition in Older Adults (version 1.2) 11/4/18 	
	 		
PARTICIPANT	INFORMATION	SHEET	
Exploring	the	Roles	of	Physical	Activity	and	Genetic	Predictors	on	Cognition	in	
Older	Adults	
Invitation	
We	would	like	to	invite	you	to	participate	in	a	research	project	investigating	whether	
physical	activity	influences	the	way	genes	might	impact	cognitive	function	(for	example	
memory	and	learning).		This	study	is	being	run	as	a	side-project	by	researchers	in	the	
Tasmanian	Healthy	Brain	Project	and	researchers	at	the	School	of	Medicine	(Psychology).	
The	study	is	being	conducted	by:	
• Dr	Christine	Padgett,	Lecturer	in	the	School	of	Medicine	(Psychology),	UTAS	
• Associate	Professor	Mathew	Summers,	Associate	Professor	of	Neuropsychology	and	
Mental	Health,	Thompson	Institute,	USC	and	Investigator	in	the	Tasmanian	Healthy	
Brain	Project,	UTAS	
• Professor	James	Vickers,	Professor	of	Pathology,	Wicking	Centre,	UTAS	
• Dr	Kimberley	Stuart,	Research	Fellow	and	Project	Co-ordinator,	The	Tasmanian	
Healthy	Brain	Project	UTAS	
• Georgina	Conley,	4th	year	Honours	Student	in	the	School	of	Medicine	(Psychology)	
• Erin	Peavey,	Clinical	Psychology	Masters	Student	in	the	School	of	Medicine	
(Psychology)	
	
1. “What	is	the	purpose	of	this	study?”	
There	is	evidence	that	some	genes	might	influence	cognitive	function	in	later	life	(for	
example,	memory	and	learning).		However,	it	is	possible	that	physical	activity	influences	
the	effect	of	these	genes.		Therefore	we	would	like	to	investigate	the	relationship	
between	physical	activity,	genes	thought	to	influence	cognition,	and	cognition	in	older	
adults.	
2. “Why	have	I	been	invited	to	participate	in	this	study?”	
You	have	been	invited	to	participate	in	this	study	because	you	are	currently	participating	
in	the	Tasmanian	Healthy	Brain	Project.	
3. “What	does	this	study	involve?”	
For	this	study,	you	would	be	asked	to	complete	two	short	questionnaires;	one	asking	
you	about	past	levels	of	physical	activity	and	the	other	asking	about	your	current	levels	
of	physical	activity.		These	questionnaires	can	be	either	completed	online	or	can	be	
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Participant	Information	Sheet	[1.2]	[11th	April	2018]		
Exploring the Roles of Physical Activity and Genetic Predictors on Cognition in Older Adults (version 1.2) 11/4/18 	
mailed	to	your	home,	where	you	can	complete	and	the	return	in	a	postage-paid	
envelope	that	we	will	provide.		Completing	the	questionnaires	should	only	take	about	10	
minutes	in	total.		You	have	a	further	option	of	having	your	physical	activity	measured	
using	an	accelerometer,	which	is	a	device	that	is	worn	to	measure	movement.		The	
accelerometer	is	worn	during	waking	hours	for	a	7	day	period.	
We	would	also	ask	that	we	could	access	the	results	of	the	cognitive	assessments	you	
have	undertaken	as	part	of	the	Tasmanian	Healthy	Brain	Project,	as	well	as	the	genetic	
results	from	the	samples	you	provided.	It	is	important	to	note	that	any	data	provided	by	
researchers	at	the	Tasmanian	Healthy	Brain	Project	would	not	have	your	name	or	any	
information	that	could	identify	who	you	are.		Only	Associate	Professor	Summers	or	Ms	
Stuart,	who	are	also	researchers	on	the	Tasmanian	Healthy	Brain	Project,	would	have	
your	identifying	information,	and	would	remove	these	details	and	insert	an	alpha-
numeric	code	in	its	place	before	passing	on	as	to	the	current	project.	
4. “Are	there	any	possible	benefits	from	participating	in	this	study?”	
It	is	not	expected	that	there	will	be	any	specific	benefits	from	participating	in	this	study.	
5. “Are	there	any	possible	risks	from	participation	in	this	study?”	
We	do	not	foresee	any	risks	associated	with	participating	in	this	study.	
6. “What	if	I	have	questions	about	this	research?”	
If	you	would	like	to	discuss	anything	about	this	study	you	are	very	welcome	to	contact	
Dr	Christine	Padgett	on	6430	4946	or	email	her	at	Christine.Padgett@utas.edu.au.		If	you	
have	concerns	or	complaints	about	the	conduct	of	this	study	should	contact	the	
Executive	Officer	of	the	HREC	(Tasmania)	Network	on	(03)	6226	7479	or	email	
human.ethics@utas.edu.au.	The	Executive	Officer	is	the	person	nominated	to	receive	
complaints	from	research	participants.	You	will	need	to	quote	HREC	project	number	
H0016623	
	
Thank	you	for	taking	the	time	to	consider	this	study.		If	you	would	like	to	take	part,	and	
have	received	this	via	email,	please	click	on	the	link	in	this	email.		This	will	take	you	to	a	
consent	form	and	then	on	to	the	survey.		If	you	have	received	this	via	mail,	please	
complete	the	enclosed	consent	form	and	enclosed	questionnaires	and	return	using	the	
postage	paid	envelope.	
This	information	sheet	is	for	you	to	keep.
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Participant	Consent	Form	[Online	1]	[June	2017]	
	
Exploring the Roles of Physical Activity and Genetic Predictors on Cognition in Older Adults (version 1.2) 11/4/18 
	
	
	
CONSENT	FORM	
Exploring	the	Roles	of	Physical	Activity	and	Genetic	Predictors	on	Cognition	in	
Older	Adults	
	
1. I	have	read	and	understood	the	information	sheet	for	this	project.	
	
2. I	understand	that	I	will	be	asked	questions	relating	to	past	and	present	physical	
activity,	and	that	this	survey	will	take	approximately	10-15	minutes	to	complete.	
	
3. I	understand	that	I	will	wear	an	accelerometer	(a	device	measuring	movement),	for	a	
period	of	7	days.		(Please	cross	out	this	point	if	you	do	not	wish	to	do	this	part	of	the	
accelerometer	study)	
	
4. I	consent	that	the	Tasmanian	Healthy	Brain	Project	can	release	my	data	to	be	
included	in	this	study.	
	
5. I	understand	that	there	are	no	foreseen	risks	associated	with	this	study.	
	
6. I	understand	that	all	research	data	will	be	securely	stored	at	the	University	of	
Tasmania	for	at	least	five	years	following	publication	of	results,	and	will	be	destroyed	
when	no	longer	required.	
	
7. Any	questions	that	I	have	asked	have	been	answered	to	my	satisfaction.	
	
8. I	agree	that	research	data	gathered	from	me	for	the	study	may	be	published	
provided	that	I	cannot	be	identified	as	a	participant.	
	
9. I	understand	that	any	information	I	provide	will	be	only	used	for	the	purposes	of	this	
research.	
	
10. I	understand	that	I	may	withdraw	at	any	time	without	any	consequences,	and	that	I	
can	request	for	my	data	to	be	removed	from	the	study	at	any	time.	
	
	
If	you	have	read	and	understood	the	information	sheet	and	above	points,	and	wish	
to	be	involved	in	the	study,	please	click	‘yes’	below	and	you	will	be	directed	to	the	
survey.		If	you	do	not	wish	to	be	part	of	this	study,	please	click	on	the	‘No’	below	and	
you	will	be	exited	from	the	survey.		We	thank	you	for	your	time.	
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Appendix C: Accelerometer Instructions and Physical Activity Diary 	
 
 
 (Participant Code:___________________)  
Physical Activity Study (HREC H0016623) Accelerometer Instructions and Diary (v1) 
Physical Activity Study 
Accelerometer Use - Instructions and Diary 
 
Thank you for you willingness to participate in this study.  The enclosed accelerometer is designed 
to be worn during waking hours, so it can be attached each morning and removed each night.  We 
would like you to wear every day it for a full week – so 7 days in a row (it doesn’t matter which day 
of the week you start on).   To use the accelerometer, please follow the instructions below.  If you 
have any concerns or questions please either contact either Christine or Kim: 
 
Christine Padgett  Phone: 6226 5718 
   Email: Christine.Padgett@utas.edu.au 
 
Kim Stuart  Phone: 6226 4286 
   Email: Kimberley.Stuart@utas.edu.au 
 
Instructions 
1. Each morning, secure the accelerometer around your waist using the supplied band, and 
adjust to fit firmly, placing it about your right leg (see image below). 
2. The accelerometer can be worn either over or under clothing, whichever you prefer. 
3. Each night, remove the accelerometer before going to bed. 
4. Please also complete the diary every day (see overleaf). 
5. At the end of the 7 day period, please return the accelerometer and diary using the reply 
paid envelope provided. 
 
NOTE: While the accelerometer is water resistant, please remove it for any water activities 
(showering, swimming etc).   
 
Example of how the ActiGraph Accelerometer is worn. 
(From https://www.actigraphcorp.com/actigraph-wgt3x-bt/) 
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 (Participant Code:___________________)  
Physical Activity Study (HREC H0016623) Accelerometer Instructions and Diary (v1) 
7 Day Diary        
Please complete this diary for the 7 days you are using the accelerometer.  If you forget to use the 
accelerometer on a given day, please still complete the diary for that day. 
Please return this diary with the accelerometer. 
Day Date Accelerometer worn? (Yes/No) 
Did you do any specific activities for 
exercise? 
If so, please specify 
For how long 
was each 
activity done? 
Example 
entry 
1/1/18 Y (but took off 
for shower 
9.00am – 
9.15 am) 
1. Walking 
2. Yoga class 
 
30 mins 
45 mins 
 
1  
 
 
 
  
 
 
 
 
 
2  
 
 
 
  
 
 
 
 
 
3  
 
 
 
  
 
 
 
 
 
4  
 
 
 
  
 
 
 
 
 
5  
 
 
 
  
 
 
 
 
 
6  
 
 
 
  
 
 
 
 
 
7  
 
 
 
  
 
 
 
 
 
Thanks again for your time! 
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Appendix D: Invitation to Participate 	
 
Mail-Out	Release	14/05/18		
Mail-Out	Invitation	
Dear	[name	inserted]	
Many	of	you	completed	the	physical	activity	survey	last	year,	and	we	would	like	to	say	thank	you	
once	again	to	everyone	who	has	participated,	we	greatly	appreciate	it!			
As	you	might	have	seen	in	the	recent	newsletter,	Dr	Christine	Padgett	is	still	conducting	resesarch	
investigating	the	effect	of	physical	activity	on	later-life	cognitive	function.		So	if	you	have	not	
completed	this	survey	but	are	interested	in	doing	so,	it	will	simply	be	a	case	of	completing	a	short	10	
minute	questionnaire,	either	online	or	by	mail.		You	would	also	be	asked	to	allow	us	to	use	the	
cognitive	assesments	and	genetic	results	you	have	already	provided	the	Tasmanian	Healthy	Brain	
Project.		All	information	will	be	provided	to	us	without	any	details	that	could	identify	you.		There	is	
no	obligation	to	be	part	of	this	additional	study,	but	we	would	appreciate	your	involvement.			
We	are	introducing	another	tool	into	the	physical	activity	study.		Accelerometers	are	small	devices	
that	are	worn	during	the	day,	which	measure	daily	activity.		We	are	hoping	that	people	who	have	
previously	completed	our	physical	activity	survey,	or	who	would	like	to	do	so	in	the	coming	months,	
will	also	be	interested	in	using	this	additional	measure.	The	details	are	provided	below.	
Please	note,	if	you	are	interested	in	just	completing	the	survey	but	not	using	the	accelerometers	that	
is	fine.		However,	to	be	part	of	the	accelerometer	study,	you	will	need	to	have	participated	in	the	
physical	activity	survey.	
If	you	haven’t	done	the	physical	activity	survey	yet,	but	would	like	to:	
Please	read	the	enclosed	information	sheet,	and	if	you	are	still	willing	to	participate,	it	will	simply	be	
a	case	of	completing	the	enclosed	questionnaire	and	consent	form.		This	should	take	about	10	
minutes,	and	once	completed,	you	can	send	back	in	the	enclosed	pre-paid	envelope.		If	you	prefer	to	
do	an	online	version	of	the	survey,	please	let	us	know	and	we	can	send	out	an	email	link.	
If	you	would	like	to	also	be	included	in	the	accelerometer	study:	
The	accelerometers	are	worn	throughout	the	day	for	a	7	day	period.		They	will	be	mailed	to	you,	
along	with	an	instruction	sheet	and	diary	to	record	the	accelerometer	use.		We’ll	also	provide	a	
reply-paid	envelope	to	return	them.		If	you	are	interested	in	this	part	of	the	study,	please	contact	Dr	
Christine	Padgett	(email	Christine.Padgett@utas.edu.au,	or	phone	6226	5718)	or	Dr	Kimberley	Stuart	
at	the	Tasmanian	Healthy	Brain	Project	(email	Kimberley.Stuart@utas.edu.au,	or	phone	6226	4286).	
	
Thank	you	for	your	time!		
	
Christine	Padgett,	on	behalf	of	the	research	team.	
	
	
